Sperduto, Paul W <br/><br/>
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  08 2017 
 - 1069-1077 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2017.03.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Brain Neoplasms--genetics<br/>Female<br/>Genes, ras<br/>Humans<br/>Immunotherapy<br/>Linear Models<br/>Male<br/>Melanoma--genetics<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Mutation<br/>Prognosis<br/>Proportional Hazards Models<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins c-kit--genetics<br/>Retrospective Studies<br/>Statistics, Nonparametric<br/>Time Factors